A NEW FLUORIDE PREPARATION FOR THE PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS - CALCIUM MONOFLUOROPHOSPHATE

被引：5

作者：

AFFINITO, P

DICARLO, C

PRIMIZIA, M

PETRILLO, G

NAPOLITANO, V

TREMOLATERRA, F

NAPPI, C

机构：

[1] Department of Obstetrics and Gynecology, School of Medicine, University 'Federico II', Naples

[2] Department of Gynecological Endocrinology, School of Medicine, University of Turin

来源：

GYNECOLOGICAL ENDOCRINOLOGY | 1993年 / 7卷 / 03期

关键词：

OSTEOPOROSIS; FLUORIDE; FLUOROCALCIC THERAPY; MENOPAUSE; BONE METABOLISM;

D O I：

10.3109/09513599309152503

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Fifty-six postmenopausal women aged 52.4 +/- 6.7 years (SD) were treated for 12 months with L-glutamine calcium monofluorophosphate. Each patient received four tablets/day, providing a total dose of 20 mg of fluoride and 600 mg of elemental calcium. Bone mineral density was measured at baseline and after 6 and 12 months of treatment by dual photon absorptiometry of the distal forearm. At these times, serum levels of alkaline phosphatase and osteocalcin, and urinary concentrations of hydroxyproline and calcium, were also assayed. Results were compared with a control group of 50 untreated postmenopausal women with similar clinical characteristics. Forty-nine patients completed the study. Bone mineral density in the treated patients showed a significant increase after 6 months in comparison with both baseline (p < 0.01) and controls (p < 0.01). After 12 months no significant further increase in bone mineral density was detected. In the control group, a significant decrease of bone mineral density was observed at this time (p < 0.01). After 6 months, serum osteocalcin levels were significantly increased in the treated group (p < 0.01 vs. basal and controls). The other biochemical parameters did not show any significant variations. After 12 months, all the biochemical parameters evaluated, with the exception of serum alkaline phosphatase, were significantly different in comparison with the control group (p < 0.01). Osteocalcin levels also increased in comparison with the basal value (p < 0.01). Adverse effects were mild. However, seven patients stopped the treatment before the 6th month because of gastrointestinal complaints. Our results seem to show that administration of calcium monofluorophosphate is an effective and safe treatment in the prevention of postmenopausal bone loss.

引用

页码：201 / 205

页数：5

共 14 条

[1]

Farley J.R., Wergedal J.E., Baylink D.J., Fluoride directly stimulates proliferation and alkaline phosphatase activity of bone-forming cells, Science, 222, pp. 330-332, (1983)

[2]

Gruber H.E., Baylink D.J., The effects of fluoride on bone, Clin. Orthop., 267, pp. 264-277, (1991)

[3]

Lau K.H.W., Farley J.R., Freeman T.K., Baylink D.J., A proposed mechanism of the mitogenic action of fluoride on bone cells: Inhibition of the activity of an osteoblastic acid phosphatase, Metabolism, 38, pp. 858-868, (1989)

[4]

Riggs B.L., Seeman E., Hodgson S.F., Taves D.R., O'Fallon W.M., Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis, N. Engl. J. Med., 306, pp. 446-450, (1982)

[5]

Briancon D., Meunier P.J., Treatment of osteoporosis with fluoride, calcium and vitamin D, Orthop. Clin. North Am., 12, pp. 629-648, (1981)

[6]

Riggs B.L., Hodgson S.F., Hoffman D.L., Kelly P.G., Johnson K.A., Taves D., Treatment of primary osteoporosis with fluoride and calcium, J. Am. Med. Assoc, 243, pp. 446-449, (1980)

[7]

Franke J., Rempel H., Franke M., Three years' experience with sodium-fluoride therapy of osteoporosis, Acta Orthop. Scand., 45, pp. 1-20, (1982)

[8]

Eriksen E.F., Mosekilde L., Melsen F., Effect of sodium fluoride, calcium, phosphate and vitamin D2 on trabecular bone balance and remodeling in osteoporosis, Bone, 6, pp. 381-389, (1985)

[9]

Riggs B.L., Baylink D.J., Kleerekoper M., Lane J.M., Melton L.J., Meunier P.J., Incidence of hip fractures in osteoporotic women treated with sodium fluoride, J. Bone Mineral Res., 2, pp. 123-126, (1987)

[10]

Riggs B.L., Hodgson S.F., O'Fallon W.M., Chao E.Y.S., Warmer H.W., Muhs J.M., Cedel S.L., Melton L.J., Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis, N. Engl. J. Med., 322, pp. 802-809, (1990)

← 1 2 →